NEW YORK (GenomeWeb News) – Gamma-Dynacare Medical Laboratories announced today the completion of its acquisition of a controlling interest in Impact Genetics.
Terms of the purchase were not disclosed.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.